CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (meta-analysis). - Magnus, Björkholm; Tomas, Andersson; Anders, Ahlbom; Eva, Ösby (European Journal of Haematology, 2008)